Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

BMC Cancer

Volumn 2, Issue , 2002, Pages

  Yu, Jian ^a   Ni, Min ^a   Xu, Jian ^a   Zhang, Hongyu ^a   Gao, Baomei ^a   Gu, Jianren ^a   Chen, Jianguo ^b   Zhang, Lisheng ^c   Wu, Mengchao ^d   Zhen, Sushen ^e   Zhu, Jingde ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

^b QIDONG LIVER CANCER INSTITUTE   (China)

^c Guangxi Cancer Institute   (China)

^d Eastern Hepatobiliary Surgery Hospital   (China)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BRCA1 PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MLH1; PROTEIN P14ARF; SURVIVIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VON HIPPEL LINDAU PROTEIN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 8; CASPASE 9; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; RASSF1 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; CELL CULTURE; CHINA; GENETICS; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASPASE 8; CASPASE 9; CASPASES; CELL CYCLE PROTEINS; CHINA; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 3042707323     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-2-29     Document Type: Article

References (43)

1. Liu Q, Wang W and eds Liver Cancer. Beijing: People's Medical Publishing House 2000,
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J and eds IARC library cataloguing in publication data cancer incidence in five continents, no.143 edn. Lyon: IARC Scientific Publications 1997,
3. Chen CJ, Yu MW and YF L Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12:S294-308
4. Feninberg A Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 2001, 98:392-394
5. Feinberg A DNA methylation, genomic imprinting and cancer. Curr Top Microbiol Immunol 2000, 249:87-99
6. Paulsen M and Ferguson-Smith AC DNA methylation in genomic imprinting, development, and disease. J Pathol 2001, 195:97-110
7. Baylin SB and Herman JG DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168-174
8. Jones PA and D T The role of DNA methylation in mammalian epigenetics. Science 2001, 293:1068-70
9. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S and Karlan BY BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 2000, 60:5329-5333
10. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN and Farrell WE Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 2000, 60:1211-1216
11. Wiencke JK, Zheng S, Lafuente A, Lafuente MJ, Grudzen C, Wrensch MR, Miike R, Ballesta A and Trias M Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:501-506
12. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC and Liaw YF Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 2001, 61:4238-4243
13. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L and Jaenisch R DNA hypomethylation leads to elevated mutation rates. Nature 1998, 395:89-93
14. Wong IH, Lo YM, Yeo W, Lau WY and Johnson PJ Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 2000, 6:3516-3521
15. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM and Johnson PJ Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999, 59:71-73
16. Wong DJ, Foster SA, Galloway DA and Reid BJ Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol 1999, 19:5642-5651
17. Hoare SF, Bryce LA, Wisman GB, Burns S, Going JJ, van der Zee AG and Keith WN Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res 2001, 61:27-32
18. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996, 93:9821-9826
19. Xing EP NY, Song Y, Yang GY, Cai YC, Wang LD and Yang CS Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999, 5:2704-13
20. Chung WB, Hong SH, Kim JA, Sohn YK, Kim BW and JW K Hypermethylation of tumor-related genes in genitourinary cancer cell lines. J Korean Med Sci 2001, 16:756-61
21. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM and Kidd VJ Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000, 6:529-535
22. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB and JG Herman Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000, 60:4366-4371
23. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001, 61:249-255
24. Graff JR, Herman JG, Myohanen S, Baylin SB and Vertino PM Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997, 272:22322-22329
25. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J and Sidransky D Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001, 61:939-942
26. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ and Huang DP High frequency of promoter hypermethylation of RASSF1a in nasopharyngeal carcinoma. Cancer Res 2001, 61:3877-3881
27. Hattori M, Sakamoto H, Satoh K and Yamamoto T DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and SURVIVIN genes. Cancer Lett 2001, 169:155-164
28. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW Inactivation of the apoptosis effector Apaf1 in malignant melanoma. Nature 2001, 409:207-211
29. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH and Sun Y Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP3). Carcinogenesis 1996, 17:1805-1811
30. Sherr C Cancer Cell Cycles. Science 1996, 274:1672-2677
31. Foster SA, Wong DJ, Barrett MT and Galloway DA Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 1998, 18:1793-1801
32. Hannon GJ and Beach D p15INK4b is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261
33. Stone S DP, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L and Kamb A Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 1995, 11:987-991
34. Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, Vanrumbeke M and Fenaux P Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998, 91:2985-2990
35. Merlo A HJ, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1995, 1:686-692
36. Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ and Muschel RJ McKenna WG: The Ras radiation resistance pathway. Cancer Res 2001, 61:4278-4282
37. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER and Latif F Methylation associated inactivation of RASSF1a from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001, 20:1509-1518
38. Dammann R, Takahashi T and Pfeifer GP The CpG island of the novel tumor suppressor gene RASSF1a is intensely methylated in primary small cell lung carcinomas. Oncogene 2001, 20:3563-3567
39. Toyooka KO TS, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD and Gazdar AF Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 2001, 61:4556-4560
40. Japan LCSGo TNM classification for hepatocellular carcinoma by Liver Cancer Study group. World J Surg 1989, 13:212
41. Nguyen CT, Gonzales FA and Jones PA Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 2001, 29(22):4598-606
42. Lin YW, Chen CH, Huang GT, Lee PH, Wang JT, Chen DS, Lu FJ and Sheu JC Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer 1998, 34(11):1789-95
43. Zhu JD, Allan M and Paul J The chromatin structure of the human epsilon globin gene: nuclease hypersensitive sites correlate with multiple initiation sites of transcription Nucleic Acids Res 1984, 12:9191-9204